![]() Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Jr., Wheeler W, Soler-Soler J and Swedberg K. Pulmonary Hypertension Due to Left Heart Disease: an Update. Postmarketing adverse events related to the cardioMEMS HF system. Vaduganathan M, DeFilippis EM, Fonarow GC, et al. Pulmonary artery pressure-guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS European Monitoring Study for Heart Failure (MEMS- HF). Angermann CE, Assmus B, Anker SD, et al MEMS-HF Investigators. Shavelle DM, Desai AS, Abraham WT, et al CardioMEMS Post-Approval Study Investigators. Significant reductions in heart failure hospitalizations with the pulmonary artery pressure guided HF system: preliminary observations from the cardioMEMS post approval study. Costeffectiveness of implantable pulmonary artery pressure monitoring in chronic heart failure. Sandhu AT, Goldhaber-Fiebert JD, Owens DK, et al. Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. Hipertensión Pulmonar en las Cardiopatías Izquierdas 50ġ42. Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial. Abraham WT, Stevenson LW, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Abraham WT, Adamson PB, Bourge RC, et al. Spironolactone for heart failure with preserved ejection fraction. Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM TOPCAT Investigators. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B. End-stage heart failure with pulmonary hypertension: levosimendan to evaluate for heart transplantation alone versus combined heart-lung transplantation.Transplantation. Schulze-Neick I, Luther YC, Ewert P, Lehmkuhl HB, Hetzer R and Lange PE. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. ![]() Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, de Boer RA, Drexel H, Ben Gal T, Hill L, Jaarsma T, Jankowska EA, Anker MS, Lainscak M, Lewis BS, McDonagh T, Metra M, Milicic D, Mullens W, Piepoli MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJS. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |